Par Drugs & Chemicals Share Price Live
Live Par Drugs & Chemicals Share Price Chart
Par Drugs & Chemicals Performance
Days Range
| Previous Close | ₹87.85 |
|---|---|
| Open | ₹88.98 |
| Volume | 1,70,453 |
| Day's Range | ₹88.98 - ₹100.87 |
|---|---|
| 52W Range | ₹81.01 - ₹249.80 |
| Market Cap | ₹108.10 Cr |
Par Drugs & Chemicals Fundamentals
| ROCE(TTM) | 12.39 |
|---|---|
| P/E Ratio (TTM) | 11.16 |
| P/B Ratio | 1.02 |
| Industry P/E | 40.40 |
| Debt to Equity | 0 |
| ROE | 9.10 |
| EPS (TTM) | 7.87 |
| Dividend Yield | 0 |
| Book Value | 86.50 |
| Face Value | 10 |
| ROCE(TTM) | 12.39 |
|---|---|
| P/E Ratio (TTM) | 11.16 |
| P/B Ratio | 1.02 |
| Industry P/E | 40.40 |
| Debt to Equity | 0 |
| ROE | 9.10 |
|---|---|
| EPS (TTM) | 7.87 |
| Dividend Yield | 0 |
| Book Value | 86.50 |
| Face Value | 10 |
Par Drugs & Chemicals Financials
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Net Sales | 21.38 | 22.33 | 26.05 | 28.66 |
| Expenses | 20.87 | 20.82 | 23.39 | 23.53 |
| Profit before tax | 0.77 | 2.28 | 4.48 | 5.55 |
| Operating Profit | 0.58 | 1.65 | 3.33 | 4.13 |
| Net Profit | 0.58 | 1.65 | 3.33 | 4.13 |
| ESP in Rs | 0.47 | 1.34 | 2.70 | 3.36 |
Par Drugs & Chemicals Shareholding Pattern
| Held by | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 73.37% | 73.37% | 73.37% | 73.37% | 73.37% |
| Flls | 0.09% | 0% | 0% | 0% | 0% |
| Dlls | 0% | 0% | 0% | 0% | 0% |
| Public | 26.54% | 26.63% | 26.63% | 26.63% | 26.63% |
About Par Drugs & Chemicals
Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat on 26 February 1999. Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018.
The Company began in 1982 under the vision of the founder, Late Shri Vallabhbhai J. Savani. The Company discontinued its existing pharmaceutical and chemical operations and diversified into an entirely new vertical line of business. With shareholder approval, the Company is investing in real estate & construction, clean & renewable energy, and capital markets.
At present, Company is engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.
There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx. 9,700 MTPA. Block 1- APIs, Block 2- Magnesium Hydroxide, Block 3- Fine Chemicals and Block 4- APIs/ Fine Chemicals. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals.
The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Key customers include Essential Drugs Company Limited, Taurus Chemicals (P) Limited, Pfizer Limited, United Phosphorus Limited(Samba Jammu Unit), Shiv Silica Private Limited.
The Company raised money from public through IPO by issuing 16,72,000 Equity Shares aggregating to Rs 8.53 Crore in May, 2019.
In June, 2021, the Company started a set of new production line-up i.e. one new manufacturing block, which increases production capacity within the existing product portfolio i.e. same as per existing product portfolio and market. There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx 9,700 MTPA. Block 1 - APls, Block 2 - Magnesium Hydroxide, Block 3 - Fine Chemicals and Block 4 - APls/ Fine Chemicals.
Parent Organisation
Indian Private
Managing Director
FALGUN VALLABHBHAI SAVANI
Founded
1999
NSE Symbol
PAR
Top Mutual Funds Invested in Par Drugs Chemicals Share
Top Mutual Funds Invested in Par Drugs Chemicals Share
| FUND NAME | AUM(%) |
|---|---|
Peer Comparison
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,806.0 -12.30 (-0.68%) | ₹4,36,343.06 | 1,548.0 - 1,910.0![]() |
| Divis Laboratories Ltd | 6,445.5 -23.50 (-0.36%) | ₹1,71,774.10 | 4,955.0 - 7,071.5![]() |
| Torrent Pharmaceuticals Ltd | 3,793.1 -2.60 (-0.07%) | ₹1,28,659.33 | 2,886.45 - 3,882.2![]() |
| Cipla Ltd | 1,518.3 -2.70 (-0.18%) | ₹1,22,878.16 | 1,335.0 - 1,673.0![]() |
| Dr Reddys Laboratories Ltd | 1,278.2 0.60 (0.05%) | ₹1,06,581.13 | 1,020.0 - 1,405.9![]() |
| Lupin Ltd | 2,103.3 11.30 (0.54%) | ₹95,552.36 | 1,795.2 - 2,402.9![]() |
Popular stocks
Par Drugs Chemicals Ltd FAQs
What is the share price of Par Drugs Chemicals Ltd (PAR) shares?
Par Drugs Chemicals Ltd (PAR) share price as of December 5, 2025, on NSE is Rs 96.84 (NSE) and Rs 96.84 (BSE) on BSE.
Can I buy Par Drugs Chemicals Ltd (PAR) from Angel One?
Yes, You can buy Par Drugs Chemicals Ltd (PAR) shares by opening a Demat account with Angel One.
How do I buy Par Drugs Chemicals Ltd (PAR) from Angel One?
Par Drugs Chemicals Ltd (PAR) share can be bought through the following modes:
1. Direct investment: You can buy Par Drugs Chemicals Ltd (PAR) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Par Drugs Chemicals Ltd (PAR) shares.
1. Direct investment: You can buy Par Drugs Chemicals Ltd (PAR) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Par Drugs Chemicals Ltd (PAR) shares.




